STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others. Its Corporate and other segment includes the Defense and Industrial business unit.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: Health Care Equipment
- Symbol: NYSE:STE
- CUSIP: 85915210
- Web: www.steris.com
Capitalization:- Market Cap: $7.42 billion
- Outstanding Shares: 85,230,000
Average Prices:- 50 Day Moving Avg: $85.66
- 200 Day Moving Avg: $78.30
- 52 Week Range: $63.80 - $88.11
P/E:- Trailing P/E Ratio: 62.26
- Foreward P/E Ratio: 19.17
- P/E Growth: 2.14
Sales & Book Value:- Annual Revenue: $2.58 billion
- Price / Sales: 2.88
- Book Value: $34.35 per share
- Price / Book: 2.53
Dividend:- Annual Dividend: $1.24
- Dividend Yield: 1.4%
Profitability:- EBIDTA: $521.33 million
- Net Margins: 4.63%
- Return on Equity: 11.39%
- Return on Assets: 6.54%
Debt:- Debt-to-Equity Ratio: 0.51%
- Current Ratio: 2.91%
- Quick Ratio: 2.30%
Misc:- Average Volume: 505,836 shs.
- Beta: 1.29
- Short Ratio: 6.71
Frequently Asked Questions for Steris Plc (NYSE:STE)
What is Steris Plc's stock symbol?
Steris Plc trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."
How often does Steris Plc pay dividends? What is the dividend yield for Steris Plc?
Steris Plc announced a quarterly dividend on Tuesday, August 8th. Stockholders of record on Tuesday, August 29th will be paid a dividend of $0.31 per share on Thursday, September 28th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Friday, August 25th. This is a positive change from Steris Plc's previous quarterly dividend of $0.28. View Steris Plc's Dividend History.
How were Steris Plc's earnings last quarter?
Steris Plc (NYSE:STE) issued its quarterly earnings data on Tuesday, August, 8th. The company reported $0.85 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.80 by $0.05. The company had revenue of $608 million for the quarter, compared to analysts' expectations of $597.66 million. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The company's quarterly revenue was down 4.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.79 earnings per share. View Steris Plc's Earnings History.
When will Steris Plc make its next earnings announcement?
What guidance has Steris Plc issued on next quarter's earnings?
Steris Plc updated its FY18 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of $3.96-4.09 for the period, compared to the Thomson Reuters consensus estimate of $4.04.
Where is Steris Plc's stock going? Where will Steris Plc's stock price be in 2017?
5 brokerages have issued 12 month price objectives for Steris Plc's stock. Their forecasts range from $71.00 to $95.00. On average, they expect Steris Plc's share price to reach $85.00 in the next year. View Analyst Ratings for Steris Plc.
Who are some of Steris Plc's key competitors?
Some companies that are related to Steris Plc include DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Bio-Rad Laboratories (BIO), DexCom (DXCM), Hill-Rom Holdings (HRC), VWR Corporation (VWR), Integra LifeSciences Holdings Corporation (IART), ICU Medical (ICUI), LivaNova PLC (LIVN), Neogen Corporation (NEOG), NuVasive (NUVA), Nevro Corp. (NVRO), Haemonetics Corporation (HAE), Halyard Health (HYH), Inogen (INGN), MiMedx Group (MDXG), CONMED Corporation (CNMD) and OraSure Technologies (OSUR).
Who are Steris Plc's key executives?
Steris Plc's management team includes the folowing people:
- Michael J. Tokich, Chief Financial Officer, Senior Vice President, Treasurer
- Karen Burton, Chief Financial Officer, Chief Accounting Officer, Vice President, Controller
- J. Adam Zangerle, Company Secretary
- Richard C. Breeden, Director
- Bruce A. Edwards, Director
- Cynthia L. Feldmann CPA, Director
- Jacqueline B. Kosecoff Ph.D., Director
- David Baker Lewis, Director
Who owns Steris Plc stock?
Steris Plc's stock is owned by a number of of retail and institutional investors. Top institutional investors include Janus Henderson Group PLC (9.01%), BlackRock Inc. (8.27%), Vanguard Group Inc. (8.09%), FMR LLC (4.06%), State Street Corp (2.74%) and Westfield Capital Management Co. LP (2.63%). Company insiders that own Steris Plc stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Kevin M Mcmullen, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris Plc.
Who sold Steris Plc stock? Who is selling Steris Plc stock?
Steris Plc's stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Paulson & CO. Inc., Hermes Investment Management Ltd., Frontier Capital Management Co. LLC, Cramer Rosenthal Mcglynn LLC, Prudential Financial Inc., Westfield Capital Management Co. LP and Franklin Resources Inc.. Company insiders that have sold Steris Plc stock in the last year include Cynthia L Feldmann, Daniel A Carestio, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Insider Buying and Selling for Steris Plc.
Who bought Steris Plc stock? Who is buying Steris Plc stock?
Steris Plc's stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, BlackRock Inc., Bessemer Group Inc., Koch Industries Inc., Principal Financial Group Inc., FMR LLC, State Street Corp and Harbour Capital Advisors LLC. View Insider Buying and Selling for Steris Plc.
How do I buy Steris Plc stock?
Shares of Steris Plc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Steris Plc's stock price today?
One share of Steris Plc stock can currently be purchased for approximately $87.04.
MarketBeat Community Rating for Steris Plc (NYSE STE)MarketBeat's community ratings are surveys of what our community members think about Steris Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Steris Plc (NYSE:STE) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Hold Ratings, 3 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.60) |
| Consensus Price Target: | $85.00 (2.34% downside) |
Analysts' Ratings History for Steris Plc (NYSE:STE)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/9/2017 | Raymond James Financial, Inc. | Boost Price Target | Outperform | $90.00 -> $95.00 | Low |  |
| 6/5/2017 | Wellington Shields | Downgrade | Gradually Accumulate -> Hold | | Low | |
| 5/3/2017 | KeyCorp | Upgrade | Sector Weight -> Overweight | $89.00 | High | |
| 11/30/2016 | Goldman Sachs Group, Inc. (The) | Initiated Coverage | Neutral | $71.00 | N/A | |
| 11/4/2016 | JMP Securities | Reiterated Rating | Buy | | N/A | |
| 6/3/2016 | Northcoast Research | Upgrade | Neutral -> Buy | | N/A | |
(Data available from 9/25/2015 forward)
Earnings History for Steris Plc (NYSE:STE)Earnings History by Quarter for Steris Plc (NYSE STE)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/31/2017 | | $0.95 | | | | | N/A | |
| 8/8/2017 | Q1 2018 | $0.80 | $0.85 | $597.66 million | $608.00 million | View | Listen | |
| 5/9/2017 | Q4 | $1.07 | $1.11 | $673.47 million | $681.20 million | View | Listen | |
| 2/7/2017 | Q317 | $1.04 | $0.98 | $680.13 million | $646.80 million | View | Listen | |
| 11/2/2016 | Q217 | $0.90 | $0.89 | $670.24 million | $646.40 million | View | N/A | |
| 8/9/2016 | Q117 | $0.77 | $0.79 | $639.04 million | $638.40 million | View | Listen | |
| 5/18/2016 | Q416 | $1.04 | $0.90 | $701.92 million | $690.30 million | View | Listen | |
| 2/9/2016 | Q316 | $0.94 | $0.98 | $617.35 million | $618.70 million | View | N/A | |
| 10/30/2015 | Q216 | $0.76 | $0.83 | $488.66 million | $489.90 million | View | Listen | |
| 8/4/2015 | Q415 | $0.61 | $0.62 | $439.23 million | $439.90 million | View | Listen | |
| 5/7/2015 | Q4 | $0.89 | $0.98 | $520.07 million | $501.60 million | View | Listen | |
| 2/4/2015 | Q315 | $0.73 | $0.79 | $475.22 million | $473.20 million | View | Listen | |
| 11/4/2014 | Q215 | $0.62 | $0.68 | $452.50 million | $462.70 million | View | Listen | |
| 8/5/2014 | Q115 | $0.54 | $0.54 | $418.26 million | $412.60 million | View | Listen | |
| 5/8/2014 | Q4 | $0.86 | $0.91 | $455.92 million | $465.30 million | View | Listen | |
| 2/5/2014 | Q314 | $0.69 | $0.59 | $406.40 million | $405.60 million | View | Listen | |
| 10/30/2013 | Q214 | $0.54 | $0.55 | $376.82 million | $383.80 million | View | Listen | |
| 8/7/2013 | Q1 2014 | $0.56 | $0.44 | $372.69 million | $367.70 million | View | Listen | |
| 5/7/2013 | Q4 2013 | $0.65 | $0.70 | $405.79 million | $426.20 million | View | Listen | |
| 2/6/2013 | Q3 2013 | $0.56 | $0.58 | $368.84 million | $380.40 million | View | Listen | |
| 10/31/2012 | Q213 | $0.52 | $0.53 | $350.23 million | $356.30 million | View | N/A | |
| 8/2/2012 | | $0.44 | $0.53 | | | View | N/A | |
| 5/8/2012 | | $0.60 | $0.59 | | | View | N/A | |
| 2/7/2012 | | $0.60 | $0.58 | | | View | N/A | |
| 11/2/2011 | | $0.57 | $0.50 | | | View | N/A | |
| 8/2/2011 | | $0.50 | $0.46 | | | View | N/A | |
| 5/9/2011 | | $0.62 | $0.61 | | | View | N/A | |
| 2/8/2011 | | $0.58 | $0.57 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Steris Plc (NYSE:STE)2017 EPS Consensus Estimate: $3.78
2018 EPS Consensus Estimate: $4.03
2019 EPS Consensus Estimate: $4.51
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.75 | $0.80 | $0.78 |
| Q2 2017 | 2 | $0.88 | $0.93 | $0.91 |
| Q3 2017 | 2 | $1.02 | $1.04 | $1.03 |
| Q4 2017 | 2 | $1.06 | $1.08 | $1.07 |
| Q1 2018 | 2 | $0.80 | $0.82 | $0.81 |
| Q2 2018 | 2 | $0.92 | $0.95 | $0.94 |
| Q3 2018 | 2 | $1.08 | $1.10 | $1.09 |
| Q4 2018 | 2 | $1.18 | $1.20 | $1.19 |
| Q1 2019 | 1 | $0.95 | $0.95 | $0.95 |
| Q2 2019 | 1 | $1.06 | $1.06 | $1.06 |
| Q3 2019 | 1 | $1.21 | $1.21 | $1.21 |
| Q4 2019 | 1 | $1.29 | $1.29 | $1.29 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Steris Plc (NYSE:STE)| Next Dividend: | 9/28/2017 |
| Annual Dividend: | $1.24 |
| Dividend Yield: | 1.42% |
| Dividend Growth: | 9.80% (3 Year Average) |
| Payout Ratio: | 88.57% (Trailing 12 Months of Earnings)
30.54% (Based on This Year's Estimates)
27.31% (Based on Next Year's Estimates)
|
| Track Record: | 7 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Steris Plc (NYSE STE)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 8/8/2017 | Quarterly | $0.31 | 1.46% | 8/25/2017 | 8/29/2017 | 9/28/2017 |
| 5/9/2017 | Quarterly | $0.28 | | 6/5/2017 | 6/7/2017 | 6/29/2017 |
| 2/7/2017 | Quarterly | $0.28 | 1.67% | 2/24/2017 | 2/28/2017 | 3/28/2017 |
| 11/2/2016 | Quarterly | $0.28 | 1.69% | 11/21/2016 | 11/23/2016 | 12/21/2016 |
| 8/9/2016 | Quarterly | $0.28 | 1.6% | 8/26/2016 | 8/30/2016 | 9/27/2016 |
| 5/18/2016 | quarterly | $0.25 | 1.43% | 6/6/2016 | 6/8/2016 | 6/29/2016 |
| 2/9/2016 | Quarterly | $0.25 | | 2/26/2016 | 3/1/2016 | 3/29/2016 |
| 10/19/2015 | quarterly | $0.25 | 1.45% | 10/28/2015 | 10/30/2015 | 12/18/2015 |
| 8/5/2015 | quarterly | $0.25 | 1.45% | 8/21/2015 | 8/25/2015 | 9/22/2015 |
| 5/7/2015 | quarterly | $0.23 | 1.35% | 6/1/2015 | 6/3/2015 | 6/25/2015 |
| 2/5/2015 | quarterly | $0.23 | 1.36% | 2/23/2015 | 2/25/2015 | 3/25/2015 |
| 11/5/2014 | quarterly | $0.23 | 1.47% | 11/24/2014 | 11/26/2014 | 12/23/2014 |
| 8/6/2014 | quarterly | $0.23 | 1.79% | 8/22/2014 | 8/26/2014 | 9/23/2014 |
| 5/14/2014 | quarterly | $0.21 | 1.58% | 6/3/2014 | 6/5/2014 | 6/26/2014 |
| 2/6/2014 | quarterly | $0.21 | 1.91% | 2/24/2014 | 2/26/2014 | 3/26/2014 |
| 10/30/2013 | | $0.21 | | 11/18/2013 | 11/20/2013 | 12/18/2013 |
| 8/7/2013 | quarterly | $0.21 | 1.91% | 8/26/2013 | 8/28/2013 | 9/25/2013 |
| 5/8/2013 | quarterly | $0.19 | 1.69% | 5/31/2013 | 6/4/2013 | 6/25/2013 |
| 2/7/2013 | quarterly | $0.19 | 1.93% | 2/25/2013 | 2/27/2013 | 3/27/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Steris Plc (NYSE:STE)Insider Ownership Percentage: 2.55%
Institutional Ownership Percentage: 93.33%
Insider Trades by Quarter for Steris Plc (NYSE:STE)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/8/2017 | Richard Martin Steeves | Director | Sell | 156,072 | $87.13 | $13,598,553.36 | |
| 8/16/2017 | Walter M Rosebrough Jr | CEO | Sell | 10,000 | $85.69 | $856,900.00 | |
| 8/15/2017 | Karen L Burton | VP | Sell | 3,270 | $85.70 | $280,239.00 | |
| 8/9/2017 | Mohsen Sohi | Director | Sell | 2,744 | $85.98 | $235,929.12 | |
| 7/3/2017 | Michael B Wood | Director | Sell | 4,000 | $81.50 | $326,000.00 | |
| 6/16/2017 | Kathleen Bardwell | Insider | Sell | 3,795 | $82.00 | $311,190.00 | |
| 6/13/2017 | Daniel A. Carestio | Insider | Sell | 4,745 | $80.08 | $379,979.60 | |
| 6/2/2017 | Walter M. Rosebrough, Jr. | CEO | Sell | 10,000 | $80.05 | $800,500.00 | |
| 6/1/2017 | Kathleen Bardwell | Insider | Sell | 4,000 | $79.00 | $316,000.00 | |
| 6/1/2017 | Sudhir K Pahwa | VP | Sell | 3,000 | $79.07 | $237,210.00 | |
| 5/25/2017 | Sudhir K. Pahwa | VP | Sell | 800 | $77.28 | $61,824.00 | |
| 5/9/2017 | Michael J Tokich | CFO | Sell | 13,600 | $76.00 | $1,033,600.00 | |
| 5/9/2017 | Sudhir K. Pahwa | VP | Sell | 200 | $77.00 | $15,400.00 | |
| 5/3/2017 | Daniel A Carestio | Insider | Sell | 7,590 | $75.17 | $570,540.30 | |
| 5/3/2017 | John Adam Zangerle | VP | Sell | 3,150 | $75.00 | $236,250.00 | |
| 5/3/2017 | Michael B Wood | Director | Sell | 4,000 | $75.00 | $300,000.00 | |
| 5/3/2017 | Michael J Tokich | CFO | Sell | 2,000 | $75.00 | $150,000.00 | |
| 2/13/2017 | Mohsen Sohi | Director | Sell | 3,387 | $67.66 | $229,164.42 | |
| 1/17/2017 | Kathleen Bardwell | Insider | Sell | 1,962 | $68.78 | $134,946.36 | |
| 12/13/2016 | John Adam Zangerle | VP | Sell | 3,100 | $69.00 | $213,900.00 | |
| 12/8/2016 | Daniel A Carestio | Insider | Sell | 2,225 | $67.54 | $150,276.50 | |
| 11/15/2016 | John Adam Zangerle | VP | Sell | 2,200 | $67.00 | $147,400.00 | |
| 11/4/2016 | Cynthia L Feldmann | Director | Sell | 4,744 | $64.98 | $308,265.12 | |
| 9/7/2016 | Richard Martin Steeves | Director | Sell | 204,778 | $71.19 | $14,578,145.82 | |
| 8/31/2016 | Adrian Vincent Coward | Insider | Sell | 15,000 | $69.00 | $1,035,000.00 | |
| 8/26/2016 | Sudhir K. Pahwa | VP | Sell | 1,028 | $70.13 | $72,093.64 | |
| 8/17/2016 | Walter M. Rosebrough, Jr. | CEO | Sell | 15,000 | $71.08 | $1,066,200.00 | |
| 8/12/2016 | Daniel A. Carestio | Insider | Sell | 2,681 | $71.04 | $190,458.24 | |
| 2/17/2016 | Walter M. Rosebrough, Jr. | CEO | Sell | 10,000 | $64.27 | $642,700.00 | |
| 11/18/2015 | Walter M Rosebrough Jr | CEO | Sell | 11,960 | $75.58 | $903,936.80 | |
| 11/9/2015 | Kathleen Bardwell | insider | Sell | 2,496 | $73.85 | $184,329.60 | |
| 11/9/2015 | Kevin M. Mcmullen | Director | Sell | 8,000 | $73.73 | $589,840.00 | |
| 11/3/2015 | Mohsen Sohi | Director | Sell | 3,000 | $76.36 | $229,080.00 | |
| 10/30/2015 | Daniel A. Carestio | insider | Sell | 6,270 | $74.00 | $463,980.00 | |
| 10/28/2015 | Sudhir K Pahwa | VP | Sell | 1,000 | $70.09 | $70,090.00 | |
| 9/30/2015 | Walter M Rosebrough Jr | CEO | Sell | 5,000 | $64.92 | $324,600.00 | |
| 9/29/2015 | Walter M Rosebrough Jr | CEO | Sell | 10,000 | $64.43 | $644,300.00 | |
| 6/15/2015 | David Allen Johnson | VP | Sell | 1,826 | $63.08 | $115,184.08 | |
| 6/10/2015 | Walter M Rosebrough Jr | CEO | Sell | 20,000 | $63.80 | $1,276,000.00 | |
| 6/9/2015 | Walter M Rosebrough Jr | CEO | Sell | 5,000 | $63.56 | $317,800.00 | |
| 8/11/2014 | Michael B Wood | Director | Sell | 5,300 | $51.79 | $274,487.00 | |
| 6/2/2014 | John Adam Zangerle | VP | Sell | 2,000 | $53.45 | $106,900.00 | |
| 5/12/2014 | John Wareham | Director | Sell | 15,000 | $55.09 | $826,350.00 | |
| 4/2/2014 | Michael Tokich | CFO | Sell | 4,525 | $51.68 | $233,852.00 | |
| 1/8/2014 | Michael Tokich | CFO | Sell | 4,200 | $48.72 | $204,624.00 | |
| 11/26/2013 | Cynthia Feldmann | Director | Sell | 6,254 | $45.97 | $287,496.38 | |
| 8/8/2013 | Timothy Chapman | SVP | Sell | 10,000 | $43.84 | $438,400.00 | |
| 6/12/2013 | Kevin M Mcmullen | Director | Sell | 10,000 | $44.09 | $440,900.00 | |
| 5/30/2013 | Walter M Rosebrough Jr | CEO | Sell | 2,000 | $45.72 | $91,440.00 | |
| 5/22/2013 | Mohsen Sohi | Director | Sell | 10,000 | $45.21 | $452,100.00 | |
| 5/21/2013 | William L Aamoth | Treasurer | Sell | 6,150 | $45.96 | $282,654.00 | |
| 5/13/2013 | David Allen Johnson | VP | Sell | 2,680 | $44.99 | $120,573.20 | |
| 10/5/2012 | Michael J Tokich | CFO | Sell | 4,100 | $37.00 | $151,700.00 | |
| 8/9/2012 | Cynthia L Feldmann | Director | Sell | 23,122 | $34.05 | $787,304.10 | |
(Data available from 1/1/2013 forward)
Headline Trends for Steris Plc (NYSE:STE)
Latest Headlines for Steris Plc (NYSE:STE)
| Source: |
|
| Date | Headline |
|---|
 | STERIS Plc : STE-US: Dividend Analysis : August 29th, 2017 (record date) : By the numbers : September 21, 2017
finance.yahoo.com - September 23 at 9:00 AM |
 | Head to Head Comparison: Steris Plc (STE) and Its Competitors
www.americanbankingnews.com - September 22 at 2:20 AM |
| Steris Plc (STE) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - September 19 at 2:38 AM |
| $630.00 Million in Sales Expected for STERIS PLC (STE) This Quarter
www.americanbankingnews.com - September 16 at 9:22 AM |
| Zacks: Analysts Anticipate Steris Plc (STE) Will Announce Earnings of $0.96 Per Share
www.americanbankingnews.com - September 14 at 10:33 AM |
| STERIS PLC (STE) Director Sells $13,598,553.36 in Stock
www.americanbankingnews.com - September 12 at 7:32 PM |
| Earnings Review and Free Research Report: Steris Reported Strong Results with Growth in Net Income and Earnings
finance.yahoo.com - August 29 at 8:16 AM |
| Zacks: Analysts Anticipate Steris Plc (STE) Will Announce Quarterly Sales of $630.00 Million
www.americanbankingnews.com - August 28 at 1:06 AM |
| Brokerages Anticipate Steris Plc (STE) to Post $0.96 EPS
www.americanbankingnews.com - August 26 at 10:04 PM |
| Steris Plc (STE) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - August 22 at 1:58 PM |
| Stryker (SYK) to Gain From Solid Portfolio and Acquisitions
finance.yahoo.com - August 21 at 9:08 AM |
| Steris Plc (STE) Raises Dividend to $0.31 Per Share
www.americanbankingnews.com - August 20 at 7:56 AM |
 | Form 4 Steris plc For: Aug 16 Filed by: Rosebrough Walter M Jr
www.streetinsider.com - August 18 at 7:32 AM |
| Steris Plc (STE) VP Sells $280,239.00 in Stock
www.americanbankingnews.com - August 17 at 7:58 PM |
| Insider Selling: Steris Plc (STE) CEO Sells 10,000 Shares of Stock
www.americanbankingnews.com - August 17 at 7:38 PM |
 | Varian (VAR) Rides on Oncology and Proton Therapy Businesses
www.zacks.com - August 16 at 7:50 AM |
| Featured Company News - Intuitive Surgical Splits Stock in Three for One Ratio
finance.yahoo.com - August 15 at 7:21 AM |
| Reviewing CareFusion (CFN) and STERIS PLC (NYSE:STE)
www.americanbankingnews.com - August 12 at 4:22 PM |
| Insider Selling: Steris Plc (NYSE:STE) Director Sells 2,744 Shares of Stock
www.americanbankingnews.com - August 11 at 8:16 PM |
| IHS Markit Score downgrades Steris PLC to 64 out of 100, ranking positively in only one out of three available IHS Markit categories.
finance.yahoo.com - August 10 at 9:10 PM |
| STERIS PLC (NYSE:STE) Expected to Post Quarterly Sales of $622.87 Million
www.americanbankingnews.com - August 10 at 12:47 PM |
| Q3 2018 EPS Estimates for Steris Plc Lowered by Analyst (NYSE:STE)
www.americanbankingnews.com - August 10 at 12:34 PM |
| KeyCorp Comments on STERIS PLC's Q2 2018 Earnings (NYSE:STE)
www.americanbankingnews.com - August 10 at 12:08 PM |
| See what the IHS Markit Score report has to say about Steris PLC.
finance.yahoo.com - August 10 at 8:21 AM |
| STERIS (STE) Beats on Q1 Earnings & Revenues, Margins Up
finance.yahoo.com - August 10 at 8:21 AM |
| Steris Plc (NYSE:STE) Price Target Raised to $95.00
www.americanbankingnews.com - August 9 at 2:08 PM |
 | BRIEF-STERIS Plc reports Q1 adjusted non-gaap earnings per share $0.85
www.reuters.com - August 9 at 7:50 AM |
 | STERIS Plc (STE) Q1 2018 Results - Earnings Call Transcript
www.msn.com - August 9 at 7:50 AM |
| Investor Network: STERIS plc to Host Earnings Call
finance.yahoo.com - August 9 at 7:50 AM |
| Edited Transcript of STE earnings conference call or presentation 8-Aug-17 2:00pm GMT
finance.yahoo.com - August 9 at 7:50 AM |
| Steris beats Street 1Q forecasts
finance.yahoo.com - August 9 at 7:50 AM |
| $0.80 EPS Expected for STERIS PLC (STE) This Quarter
www.americanbankingnews.com - August 8 at 12:22 PM |
| STERIS PLC (NYSE:STE) Updates FY18 Earnings Guidance
www.americanbankingnews.com - August 8 at 10:44 AM |
| STERIS PLC (STE) Issues Earnings Results
www.americanbankingnews.com - August 8 at 9:42 AM |
| STERIS Announces Financial Results for Fiscal 2018 First Quarter
finance.yahoo.com - August 8 at 7:12 AM |
| ETFs with exposure to STERIS Plc : August 4, 2017
finance.yahoo.com - August 4 at 8:34 AM |
| STERIS PLC (STE) to Release Earnings on Tuesday
www.americanbankingnews.com - August 1 at 7:31 AM |
| Steris Plc (NYSE:STE) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 31 at 8:44 PM |
 | Operating Room Equipment Market Size Worth $48.50 Billion By 2025: Grand View Research, Inc.
www.prnewswire.com - July 27 at 7:54 AM |
| STERIS to Announce Fiscal 2018 First Quarter Financial Results on August 8, 2017
finance.yahoo.com - July 26 at 8:23 AM |
| STERIS to Announce Fiscal 2018 First Quarter Financial Results on August 8, 2017
finance.yahoo.com - July 26 at 8:23 AM |
| $593.07 Million in Sales Expected for Steris Plc (NYSE:STE) This Quarter
www.americanbankingnews.com - July 21 at 8:47 PM |
| $0.80 Earnings Per Share Expected for Steris Plc (STE) This Quarter
www.americanbankingnews.com - July 19 at 9:56 AM |
| ETFs with exposure to STERIS Plc : July 13, 2017
finance.yahoo.com - July 14 at 8:49 AM |
| Steris Plc (STE) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - July 11 at 1:04 PM |
| Michael B. Wood Sells 4,000 Shares of Steris Plc (STE) Stock
www.americanbankingnews.com - July 6 at 7:40 PM |
| Global Patient Positioning System Market 2017-2022 with AB, Hill-Rom, Stryker ...
www.prnewswire.com - June 30 at 6:58 AM |
| Today's Research Report Coverage on Medical Equipment Stocks -- Prestige Brands, Smith & Nephew, Steris, and Varian Medical Systems
www.prnewswire.com - June 29 at 7:05 AM |
| STERIS PLC (STE) Expected to Announce Quarterly Sales of $593.07 Million
www.americanbankingnews.com - June 25 at 11:20 AM |
| Steris Plc (STE) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - June 23 at 12:50 PM |
Steris Plc (STE) Chart for Monday, September, 25, 2017
